drugset / Trial / NCT01389713

Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve

NCT01389713

RandomizedParallel-groupOpen-labelTreatment

Summary

Women with compromised ovarian reserve requiring in vitro fertilization (IVF) still represent a demanding challenge for clinicians. It has classically been claimed that using higher dosages of gonadotropins may overcome the scarce ovarian responsiveness to hyper-simulation and increase the chances of success. However, scientific evidence supporting this view is scanty and costs are inevitably much higher. In this study, the investigators hypothesized that similar chances of pregnancy may be achieved with a mild stimulation using exclusively Clomiphene citrate (CC).

Timeline

Start
2008-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 150 mg
Comparator Decapeptyl Unknown 0.1 mg Subcutaneous
Comparator recombinant-human FSH Protein / enzyme biologic 450 iu

Indications